20,000-Person trial tests new combo pill for blood pressure control
NCT ID NCT05413057
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 28 times
Summary
This study will follow 20,000 adults with high blood pressure who take a single pill containing two or three medicines (fimasartan/amlodipine with or without hydrochlorothiazide). The main goal is to see how well these pills control blood pressure after 12 weeks and to track heart problems and safety over about 2 years. Participants must have essential hypertension and choose to take these medications as part of their regular care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION,ESSENTIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Bundang Hospital
RECRUITINGSeoul, South Korea
Contact
Contact
Conditions
Explore the condition pages connected to this study.